Recent epidemiologic studies implying differences in cancer recurrence based on
anesthetic regimens raise the possibility that the mu opioid receptor (MOR) can influence …

BACKGROUND: The possibility that μ opioid agonists can influence cancer recurrence is a
subject of recent interest. Epidemiologic studies suggested that there were differences in …

Background Recent epidemiologic studies suggesting that there were differences in cancer
recurrence contingent on anesthetic regimens have raised the possibility that μ-opioid …

BACKGROUND: There have been inconsistent reports on whether opioids promote or inhibit
lung cancer growth. In this study, we suggest that opioid growth factor receptor (OGFR), a …

The possibility that anesthetic drugs can influence cancer recurrence rate is a subject of
recent interest. Based on early in vitro data demonstrating opiates on breast cancer …

Background We and others have previously demonstrated that the μ-opioid receptor (MOR)
is overexpressed in several human malignancies. There is a seven-fold increase in MOR in …

BACKGROUND: Epidermal growth factor receptor (EGFR) is coactivated by the μ-opioid
receptor (MOR), expressed on non–small cell lung cancer (NSCLC) cells and human lung …

The mu-opioid receptor (MOR), a membrane-bound G protein-coupled receptor, is the main
target for opioids in the nervous system. MOR1 has been found in several types of cancer …

Background Opioid receptors are implicated in cancer progression and long-term patient
outcomes. However, the prognostic significance, underlying mechanisms, and therapeutic …

Hepatocellular carcinoma (HCC) is the most prevalent subtype of liver cancer. Anesthetic
regimens possibly influence cancer development. Exploration of novel, effective targets for …